Independent · English-language
Israel's cannabis industry, in English.
Independent English-language news, data and analysis on Israel's medical cannabis market — regulation, companies, research and patient access.
Latest coverage
All news →- StratCann
Week in Weed — June 20, 2026: Israel's reforms stay in focus
Weekly roundup covering Israel's medical cannabis reforms, the smokable phase-out debate and ongoing trade questions.
- PR Newswire
IM Cannabis enters letter of intent to sell its European operations, cutting debt by ~C$10.5M
IMCC will sell its European arm — including Germany's Adjupharm — to a CEO-controlled entity to reduce debt and refocus on its core Israeli business.
- Cannabis Business Times
InterCure completes first tranche of Botanico (ISHI) deal, weighs U.S. opportunities after rescheduling
Israel's largest listed operator adds American cannabis genetics and brands via Botanico and opens a strategic review of regulated U.S. markets.
- The Media Line
With trauma cases climbing, why is Israel questioning medical cannabis now?
As PTSD cases rise, a growing debate asks whether cannabis reliably helps trauma symptoms — or may worsen them.
- The Times of Israel
Amid high demand, medical cannabis experts hail 'game-changing' relaxation of rules
Experts welcome eased access rules even as the Health Ministry weighs tighter limits on smokable formats.
- The Times of Israel
Health Ministry panel seeks to halt use of medical cannabis in smokable form
A committee recommends phasing out smoked cannabis over three years, with exceptions only for patients over 75 and the terminally ill.
- StratCann
Israel's Health Ministry recommends phasing out smoked medical cannabis over three years
The Bodenheimer committee proposes moving patients to oils, extracts and precision inhalers, and shifting prescribing into the HMOs.
- GrowerIQ
Israel's cannabis market: 302,000 imported flower packages processed in a single month
A snapshot of Israel's import-heavy market: flower dominates usage and roughly a third of products are imported.
- IM Cannabis (investor relations)
IM Cannabis reports 2025 results: C$54.7M revenue, 134% Germany growth, positive operating cash flow
Germany surged to over two-thirds of group revenue as the company posted its first positive operating cash flow.
- GlobeNewswire
InterCure announces preliminary 2025 revenue of NIS 265M with positive adjusted EBITDA
Revenue up roughly 11% on 2024, with the first significant contribution from the German market in H2.
- MJBizDaily
Israel passes Germany as world's largest importer of medical cannabis flower
Israel's reliance on imported flower puts it at the top of the global import table — and at the center of the tariff debate.
- The Jerusalem Post
Bill regulating medical cannabis use passes preliminary reading in the Knesset
Legislators advance a bill aimed at clarifying and regulating access to medical cannabis.